Developer of regenerative medicines. The company's regenerative medicines include adipose derived stem cell, enabling the medical industry to increases the soft tissue of the body for fighting facial degenerative diseases.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore Biomaster‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.